The Importance of Multidisciplinary Collaboration in CRS Management
Focusing on supportive care practices, the panel discusses the critical role of effective multidisciplinary team collaboration and communication in optimizing the management of CRS and ICANS in patients receiving CAR T-cell therapy.
EP: 1.Unique Challenges in Managing Adverse Events Associated with CAR T-Cell Therapy
EP: 2.Navigating CAR T-Cell Therapy in Multiple Myeloma: A Collaborative, Patient-Centered Approach
EP: 3.Patient Profile 1: Managing CRS Following CAR T-Cell Therapy
EP: 4.Underlying Mechanisms and Signs of CRS
EP: 5.Strategies to Manage or Mitigate CRS
EP: 6.Patient Profile 2: Managing ICANS Following CAR T-Cell Therapy
EP: 7.Clinical Practices for Treating ICANS Following CAR T-Cell Therapy
Now Viewing
EP: 8.The Importance of Multidisciplinary Collaboration in CRS Management
EP: 9.Supportive Care Strategies for CAR T-Cell Therapy Recipients
EP: 10.Managing Cytopenias and HLH/MAS Following CAR T-Cell Therapy
EP: 11.Unmet Needs and Future Perspectives for CAR T-Cell Therapy in R/R MM
Video content above is prompted by the following question:
- Discuss the critical role of effective multidisciplinary team communication and coordination in optimizing the management of CRS and immune effector cell-associated neurotoxicity syndrome (ICANS) in patients receiving CAR T-cell therapy.
Recent Videos
Related Content
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
February 15th 2025Article
During the 66th American Society of Hematology Annual Meeting and Exposition, experts in multiple myeloma gathered to discuss the impact of maintenance therapy and minimal residual disease (MRD) in patients with newly diagnosed transplant-eligible or -ineligible multiple myeloma.
